- Non-invasive prenatal testing (NIPT)
- Pre-implantation genetic screening (PGS)
- Pre-implantation genetic diagnosis (PGD)
- BRCA 1 & 2 panel
- Cancer hotspot panel
- Lung Cancer mutation panel
- RAS Extended Plus for Colorectal Cancer
- Thyroid cancer mutation profile
- AML mutation panel
- GIST mutation panel
- Prostate cancer mutation panel
- ABL1 TKI resistance mutations
- MPN mutations
- TP53 mutation
- GIST mutation panel
- IDH1 & IDH2 mutations for glioma
- KIT D816V mutation
- FGFR3 mutation for bladder cancer
- BCR-ABL detection
- PML-RARA detection
- ALL translocation panel
- AML translocation panel
- HLA typing
- Paternity testing
RAS Extended Plus for Colorectal Cancer
RAS Extended Plus for Colorectal Cancer
This test includes the analysis of all KRAS & NRAS mutations that are recommended as ‘RAS extended’ testing in international guidelines for targeted treatment of Colorectal cancers*. In addition the test also includes BRAF V600E mutation testing which is recommended for colorectal cancer prognostification, and evaluation of Lynch syndrome risk. Other genes tested in the panel are PIK3CA and PTEN for informational purposes.
(*Molecular Biomarkers for the Evaluation of Colorectal Cancer Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology. J Mol Diagn. 2017 Mar; 19(2): 187–225)